Assyro AI

Orange Book product · Brand (NDA)

PREZISTA

DARUNAVIR

Brand (NDA)NDA 021976TE ABRX JANSSEN PRODS

At a glance

Dec 18, 2008

Approved

Brand (NDA)

Application

AB

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 18, 2008

    17 yr 9 mo ago

  2. Today

  3. Patent 7700645 expires

    Listed drug substance patent expiration.

    Dec 26, 2026

    in 6 mo

  4. Patent 7700645*PED expires

    Listed listed patent expiration.

    Jun 26, 2027

    in 1 yr

Pharmaceutical detail

Active ingredient

DARUNAVIR

Strength

75MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 021976

Product number

004

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7700645Dec 26, 2026in 6 mo
SubstanceProduct
7700645*PEDJun 26, 2027in 1 yr
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.